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Abstract
It has recently been reported that the duplication of the GNB3 gene has been shown to be directly linked to an 
obesity phenotype, both in humans and also in a humanised mouse model. Moreover, the common human GNB3 
c.825C>T polymorphism (rs5443) causes this ubiquitously expressed gene to be aberrantly spliced approximately 
50% of the time leading to the production of both a normal Gβ3 protein and a truncated, possibly less stable 
subunit, known as Gb3s. The presence of the GNB3 825T allele has previously been shown to be associated 
with predisposition to hypertension, obesity, various cancers, Alzheimers, age related cognitive function, erectile 
dysfunction as well as a marker for pharmacogenetic drug action. Great controversy, however, currently exists 
as to whether these phenotypes associated with the 825T allele are a) mainly due to the presence of the smaller, 
possibly more active, Gb3s subunit or b) merely down to the haploinsufficiency of the normal GNB3 transcript, 
due to its frequent aberrant splicing. In order to try and address these two conflicting hypothesis, we report on 
the identification and characterisation of signalling alterations unique to the presence of Gb3s protein subunit. 
Moreover we also show the physiological consequences associated with altered signalling, directly induced 
by the Gb3s subunit. For this, we used both an EBV transformed lymphoblast cell line homozygote for GNB3 
825T/825T (TT) and a stable Gb3s expressing recombinant COS-7 clone. In both of these cell lines that express 
the Gb3s subunit, we found enhanced cytosolic calcium influx upon stimulation with EGF, TGFα and VEGF 
ligands, as compared to “normal” GNB3 controls with the 825C/825C (CC) genotype. This aberrant calcium 
influx also led to an increase in ERK, but not AKT1, phosphorylation. Despite the lack of AKT1 activation, we 
paradoxically observed a significant increase in phosphorylation of its downstream substrates, namely mTOR 
and p70S6k (KS6B2). Moreover we observed a decrease in phospho FoxO3a only in Gb3s expressing cells, but 
not in the “normal” GNB3 (CC) control cell line. The presence of the Gb3s subunit also appeared to alter the 
distinct localisation patterns of both Foxo3a and AKT1, while also increasing the colocalisation of mTOR and 
p70S6K. Subsequent growth factor stimulation studies revealed that EGF treatment, of Gb3s expressing cells, 
appeared to cause a significant decrease in cAMP levels, which, in turn resulted in both enhanced caveolin-
1a phosphorylation, and an increase in actin stress fibre formation. The identification of these distinct Gb3s 
specific signalling alterations were indicative of a more aggressive migratory phenotype. This led us to further 
investigate and confirm that the presence of the Gb3s subunit also appears to cause significantly enhanced 
migration and robust scratch wound healing kinetics, as compared to cells harbouring only the normal copy of 
the gene. These data therefore present convincing evidence that the Gb3s subunit is stable, functional and its 
presence can significantly alter signalling pathways, in different cell types.
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Introduction
Heterotrimeric G proteins, which consist of an a, b 
and g subunit , are involved in signalling pathways 
which regulate cell migration and chemotaxis both of 
which are prerequisites for metastasis formation [1]. In 
humans, 16 different alpha genes encode Ga subunits, 5 
different GNB genes encode Gβ subunits (plus additional 
splice variants) and 12 different GNG genes encode Gγ 
subunits [2]. Gbg subunits are involved in the signalling 
of phosphatidylinositol-phosphates, i.e. phospholipase C 
(PLC) and PI3 kinase (PI3K), that contribute to regulation 
of gene expression and tumour cell migration promoting 
metastasis. Previous studies have shown the involvement 
of Gβg signaling in cell migration of endothelial [3]
and breast cancer cells [4, 5]. In contrast, Gβγ induced 
signaling was also shown to inhibit EPAC (RAPGEF3) 
induced Ca2+ elevation and cell migration, via additional 
Ca2+ influx from the extracellular space [6]. Moreover, 
Gbg signaling was shown to induce PI3K alpha and 
Src signaling that resulted in downstream activation 
of AKT and ERK through the Raf, JNK, Ras and Rac 
pathways. These in turn regulated cell motility, invasion 
and metastasis [7]. The importance of PI3K pathway in 
metastasis has previously been demonstrated in cells 
expressing a “kinase-dead” AKT mutant that resulted 
in a diminished invasion potential and inability of cells 
to form tumours or metastasize in vivo [8]. Thus, it is 
clinically important to have a complete understanding 
of pathways under the regulation of Gbg subunits and 
its intracellular effector such as ERK and AKT, which 
communicate and co-operate between different signaling 
pathways implicated in critical physiological responses. 
Following the original findings of  Siffert et al. 
[9], who first reported the association of the common 
GNB3 c.825C>T polymorphism with hypertension,  we 
later  reported a recessively inherited GNB3 mutation 
D153del,  that causes a retinopathy globe enlarged and 
a severe renal phenotype in chickens [10, 11].The GNB3 
D153delmutation was shown to significantly change 
the structure of the the Gβ3 subunit, and to alter many 
downstream effectors controlled by the secondary 
messengers cGMP and cAMP [10-11]. Such alterations in 
second messengers have been shown to have a subsequent 
effect on both the ERK and AKT, components of MAPK 
and PI3K pathways respectively [11-13].
Interestingly, a recent study has shown that both 
humans and transgenically engineered mice that carry an 
extra copy of GNB3 gene leads to obesity and increased 
weight and abdominal fat content in humans and mice 
respectively [14]. The common human polymorphic 
variant 825C>T in exon 10 of the GNB3 gene causes its 
transcript to missplice at a cryptic splice site in exon 9, 
in approximately half of all transcripts produced. This 
smaller transcript is translated into an immunologically 
detectable truncated, smaller Gb3 (Gb3s) protein subunit 
[9]. It has been hypothesized that this Gb3s protein 
subunit forms a 6 as opposed to the normal 7 WD propeller 
structure [9]. The presence of the Gb3s subunit, in GNB3 
825T cells, appears to cause hyperactivating gain in 
function and signalling activity, in the few cell types that 
have been studied [e.g. 9, 15-17]. As the 825T allele is 
found in approximately half of all human chromosomes 
by deduction the Gb3s subunit is therefore also expressed 
in approximately half of the world’s population. The 825T 
allele and also the  Gb3s subunit has been recognised 
as a predisposing factor for common diseases such as 
hypertension, Alzheimer’s disease, major depressive 
disorder, obesity, and coronary heart disease [reviewed in 
18]. 
A previous cohort study in cancer patients with 
transitional cell bladder carcinoma reported that the 
GNB3 825T polymorphism influenced the biological 
behaviour of tumour disease [19]. This study revealed 
a shorter time for metastasis in 825T-allele carriers 
compared to individuals that were homozygous for 
the GNB3 825C allele. In subsequent studies, it was 
found that individuals who were suffering from either 
oncocytic thyroid tumours, head and neck squamous cell 
carcinoma or bladder carcinoma, were at a significantly 
higher risk for tumour relapse and death when they were 
homozygous for the GNB3 825T allele [20, 21]. On the 
contrary, a different study found that the GNB3 825T 
allele appears to be protective against the development of 
bone metastasis in breast cancer patients when compared 
to individuals homozygous for the 825C allele [22]. These 
results demonstrate that the expression of the variant 
Gb3s protein, in different cell types can have different 
signalling outcomes causing different physiological 
effects. However the underlying signalling mechanisms 
that lead to such a plethora of different phenotypic 
alterations, are far from being fully elucidated, for the 
GNB3 825T allele. 
Therefore understanding the effects of the splice variant 
Gb3s protein subunit, in the Gbg signalling pathway, may 
help us explain the complex disorders that 825T GNB3 
individuals are predisposed to. However, due to the 
limited access to affected human tissues, currently only 
appropriate cellular models can be employed to decipher 
such signalling changes. B-lymphoblast cells, however, 
have previously been used as a convenient experimental 
cell system, that has led to the reproducible assessment 
and examination of complex molecular signaling 
networks [23]. Moreover the convenient use of EBV 
transformed B lymphoblast cells, as a model to study basic 
molecular mechanisms and genetic associations of human 
diseases, is becoming increasingly widespread [24-27]. 
The application of this model to explore cell signaling 
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and physiology patterns seems particularly appropriate 
given that these cells share many common molecular and 
cellular features important for cell signaling for instance, 
those that relate to cell motility and morphology. For 
example lymphoblast cell lines have previously been 
used for cell migration studies to understand neural cell 
motility, which plays a significant role in schizophrenia 
[24].
Controversy exists in whether the presence of 
Gb3s causes any signaling alterations unique to this 
truncated form leading to functional consequences, or 
if it is functionally unstable. For example, Virchow S 
et al reported that neutrophils of homozygous GNB3 
(TT) genotype displayed enhanced migration kinetics 
as compared to neutrophils of heterozygous GNB3 
825C/825T (CT) and homozygous GNB3 (CC) genotype 
[12]. On the contrary, a recent study claimed that this 
variant is an unstable protein and functionally inactive 
[28]. In order to identify whether the Gβ3s subunit is 
indeed both stable and functional we firstly used EBV 
transformed human B lymphoblasts homozygous for 
either the 825C or the 825T alleles. The former cell line 
expresses only Gβ3, while the latter cell line expresses 
approximately equal amounts of both Gβ3 and Gβ3s 
subunits. Secondly we also generated a stable COS-
7 clones expressing either a 6xHis tagged Gβ3 normal 
(Gβ3-COS) or Gβ3s mutant subunit (Gβ3s-COS). From 
experiments with these cell lines, our findings indicate that 
the Gb3s is indeed both stable and functionally active. For 
example following growth factor stimulation of our cell 
lines, the presence of Gβ3s  shows a significant rise in 
enhanced cytosolic Ca+ influx, causing an activation of 
ERK and repression of AKT phosphorylation. This in turn 
leads to a decrease in cAMP levels causing subsequent 
Caveolin 1a (Cav1) phosphorylation. These signalling 
events induced cytoskeletal remodelling leading to actin 
stress fiber formation and overall enhanced cell migration 
and scratch wound healing ability, that were unique to 
Gb3s containing cells and absent in cells containing the 
full length Gb3. Thus we illustrate a novel signaling 
mechanism induced by Gb3s following growth factor 
stimulation that results in more aggressive migratory 
phenotype. 
Materials and Methods
Cell culture and treatments 
Immortalised B-lymphoblast cell lines expressing 825CC 
(GM19116) Gb3 and 825TT (GM18500) Gb3s protein 
were obtained from Coriell Cell Repositories, USA. 
These cell lines were cultured in 10% FCS supplemented 
RPMI media (Invitrogen UK) in culture flasks. Simian 
COS-7 cells (ATCC CRL 1651) were maintained in 
DMEM (Invitrogen, UK) supplemented with 10% foetal 
bovine serum (FBS), 2 mM glutamine, 1 mM sodium 
pyruvate, 100 μg/ml streptomycin and 100U/ml penicillin 
in an atmosphere of 5% CO2. Cells were stimulated 
with Epidermal Growth Factor (EGF) or Transforming 
Growth Factor alpha (TGFa) or Vascular Endothelial 
Growth Factor (VEGF) (Invitrogen, UK). Treatments 
with inhibitors were performed with Verapamil, a calcium 
channel blocker at 20mg/ml [83], U0216, a dual MEK1 
and MEK2 inhibitor at 25mmol/ liter [84], and GRK2i 
peptide [85] (Tocris UK) for 2 hrs in DMEM containing 
1% serum. The specificity of each inhibitor treatment 
was evaluated by monitoring their functional activity 
(see Results). Cell viability was >90% for each inhibitor 
treatment as judged by trypan blue staining (Data not 
shown). Forskolin (Fsk) was purchased from Sigma 
Aldrich UK.
Plasmids, transfections and stable clones
Both (pCDNA 3.0) His tagged GNB3 and GNB3s were 
constructed by PCR amplification of pREP4-GNB3 and 
pREP4-GNB3s cDNAs obtained from Dr. M.J Bullido 
(Universidad Autónoma de Madrid, Cantoblanco, 
Madrid, Spain) using primers carrying flanking 
restriction sites forward HindIII, 6x His tag (underlined) 
5’AAGCTTATGCATCATCACCATCACCACACGG 
GGAGATGGAGCAACTG 3’ and reverse XhoI sites 
5’ CTCGAGTCAGGTTCCAGATTTTAGG 3’. PCR 
amplified fragments were digested and sub-cloned into 
pCDNA3.0. The fidelity of the constructs has been 
checked and verified by sequencing using a commercial 
sequencing service (www.dnaseq.co.uk). COS-7 cells 
were transfected using electroporation.  When they 
reached confluence at 2 x 107, cells were washed in PBS 
and resuspended in 400ml of the Optimem transfection 
media (Invitogen UK), and were electroporated using 
settings at 400V, 350mF, using Easyject EquiBio (Kent 
UK). 10mg DNA was used per transfection. Subsequently, 
stable clones expressing 6xHis-tagged Gb3 (Gb3-COS) 
and Gb3s (Gb3s-COS) were generated by selection with 
G418 (Invitrogen UK) at 800 mg/ml, and subsequently 
maintained at 400 mg/ml.  The culture was placed back 
in the incubator until individual colonies were visible. 
Individual colonies were expanded, and the level of 
6x Histidine-tagged Gb3 and Gb3s protein expression 
was determined by western blot analysis using anti-His 
antibody mentioned in Table 1.
Antibodies, immune-blotting and data presentation
Expression of Gb3 and Gb3s protein was detected using 
Anti- rabbit GNB3, anti-sera on B lymphoblast cells at 
a relevant dilution (1:2000) in blocking reagent.  The 
antibodies mentioned in table 1 are used to detect the 
expression of phosphorylated and total proteins levels in 
B lymphoblast cell lysates. Rho A, Rho B, Rho  C, Rac 
BioDiscovery | www.biodiscoveryjournal.co.uk November 2013 | Issue 9 | 34
Expression of Gβ3s leads to enhanced cell migration
Table 1. Antibodies used in the study.
Antibody Company
GNB3 EURGENE TECH
MAPK (ab17942)  Abcam
Phospho-MAPK (ab50011) Abcam
FoX03a (2497) CST
Phospho-FoX03a (9465) CST
ATK (9272) CST
Phospho-AKT (S473) CST
Phospho-AKT (T308) CST
mTOR (2972) CST
Phospho-mTOR (S2871) CST
β-Actin (ab1801) Abcam
Phospho-Caveolae-1 (ab38468) Abcam
4E-BP1 (9451) CST
Phospho-4E-BP1 (T46) CST
1-2-3 and CDC42 total and phosphorylated expression 
were determined using Rho GTPase antibody sampler 
kit (Cell signalling, UK).  Briefly, by centrifuging cells 
at 1500g for 5min, the obtained pellet was washed 
twice with ice cold PBS and centrifuged again at 1500g 
for 5 min. 1 ml of RIPA buffer (Pierce Biotechnology 
UK) was added to 40 mg of wet cell pellet, mixed well 
and then sonicated for two cycles of 5 seconds at 50% 
pulse. The final mixture was shaken gently on ice for 
15 min and the protein supernatant was obtained by 
centrifuging the cells at 14000g for 15 min. Subsequently 
all protein extract samples were quantified with the 
use of a spectrophotometer, with BSA as a standard. 
50mg cell lysates were mixed with sample buffer and 
equal concentrations were loaded on 10–12% SDS–
polyacrylamide gels. After electrophoresis, the proteins 
were transferred to nitrocellulose membranes (Bio-Rad 
Hybond ECL). Further blotting was carried out using a 
commercially available kit (QDOT® 625 Streptavidin 
conjugate kit, Invitrogen, UK). Non-specific reactivity 
was blocked by incubation with a blocking reagent 
supplied in the kit. Membranes were further processed 
by incubating them with relevant primary antibodies 
described in Table 1, washed and further incubated for 
an hour (hr) with Biotin labelled secondary antibodies. 
Finally, bands were visualized with the enhanced 
streptavidin substrate, washed and visualised under the 
UVDOC imaging system (Alpha Innotech). For internal 
control, the levels of b-actin were examined on the same 
blot by incubating the blots with stripping solution for 
1 hr (20% SDS, 67.5µM Tris-HCl of a pH 6.7, 100µm 
2- Marcaptoethanol) and reprobing with anti-b-actin 
(Sigma-Aldrich, UK) and anti-mouse IgG secondary 
antibody (Sigma-Aldrich, UK). Densitometry analyses 
on the immunoblotted images were performed by Gelpro 
software (Media Cybernetics, USA). Statistical analysis 
was performed using Graph Pad Prism (USA) and 
displayed as mean ± S.E. The significance (p value) of 
differences of pooled results was estimated by ‘t’ tests, 
and were defined as *p< 0.05.
FITC conjugated cholera toxin B (CTB) uptake, 
Immunocytochemistry (ICC), imaging and co-
localisation
Stable expressing His-Gb3 and His-Gb3s COS cells 
were grown on standard glass coverslips coated with 
polylysine (Sigma-Aldrich, UK).  They were placed 
in petri dishes containing Dulbecco’s modified Eagle’s 
medium (DMEM, Invitrogen, UK) supplemented with 
10% fetal bovine serum and allowed to grow for 18-24hrs. 
Following relevant treatments, cells were fixed in 3% 
paraformaldehyde in a standard PBS at room temperature 
for 30 minutes (min). The cells were then gently washed 
twice with 1 ml of PBS, and blocked using 1% goat serum 
and 1% bovine serum albumin in PBS containing 0.05% 
Triton X-100, for 30 min.  They were then incubated 
with a primary antibody diluted in blocking solution for 
30 min, washed three times with the 0.3% Triton X-100/
PBS for 5 min, and then incubated with the relevant 
Alexa fluor 488 and Alexa Flour 568 conjugated goat 
anti-rabbit secondary antibodies (Invitrogen UK) for 30 
mins. Fluorescent Alexa Fluor 568 phalloidin (Invitrogen 
UK) was used to visualize actin structures. For nuclear 
staining, cells were mounted with DAPI containing 
Vectashield solution (Vector Laboratories UK). Cells 
showing actin filament bundles across cell bodies were 
counted as stress fiber positive, cells showing mainly 
cortically distributed actin filaments were counted as 
stress fiber negative. Mounted cells were imaged under 
a Leica DMiRe2 electronic controlled microscope, 
under relevant excitation and emission filters depending 
on the fluorotype.  An iXonEM +897 EMCCD camera 
(ANDOR technologies ltd, USA) was used to capture 
images and visualisation was performed using multi-
dimensional microscopy software Andor Module iQ Core. 
Colocalisation assays were performed and determined 
with software integral features supplied by Andor IQ core 
software features.
Migration assay
Migration assay was performed using the 48-well 
Boyden chambers (8 μm pores, BD Biosciences). The 
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cells were plated at a density of 1 × 106 cells/100 μl 
serum-free media containing 10% BSA which was used 
as a positive control.  This was placed in the bottom 
wells of a Boyden chamber.  A medium containing 
lymphoblast cells, starved for 2 hr in serum free media, 
was added to the top chamber. For the inhibition assays, 
cells were starved for 2 hr and pre-incubated with 
inhibitors for 30 min. Inhibitors were also added to the 
cell suspension placed on the top chamber wells, and 
also to the chemoattractant added to the bottom chamber 
wells, in order to be present during the migration time. 
After 6 hr incubation the cells were stained using the 
Diff-Quick kit (Dade Behring). Pictures were taken with 
a light microscope and migrated cells were counted with 
Gelpro Software (Media cybernetics, USA) using 10 
randomly chosen fields.
Calcium influx assay
Lymphoblast cells at 125000 cells / well density were 
plated in a 96 well plate and incubated for 16hrs in 
RPMI media (Invitrogen UK). 16 hrs later RPMI media 
without serum was added prior to stimulation with EGF. 
Upon EGF stimulation at relevant time points, cytosolic 
calcium influx assay was carried out using Molecular 
Probes’ Fluo-4 NW (No-Wash) Calcium Assay Kit 
(Invitrogen UK) following the kit instructions. Calcium 
response was detected using the Modulus™ Microplate 
Multimode Reader plate reader using instrument settings 
appropriate for excitation at 494 nm and emission at 516 
nm. Functional parameters were determined with Graph 
Pad PRISM software using non-linear regression applied 
to a sigmoidal dose response model.
cAMP assay
cAMP assays were carried out  as mentioned in Tummala 
et al 2011 [11] to detect variations in the concentration 
levels of cAMP upon EGF induction at indicated time 
points in the B lymphoblasts. Briefly, the protein extracts 
acquired from B lymphoblast and COS-7 stable clones 
were acetylated following the kit instructions (Cayman 
Biosciences) to increase the sensitivity of detection. For 
cyclic nucleotide determination, protein samples are 
diluted with 0.1 M HCl that inactivates phosphodiesterases 
and lower the concentration of immunoglobulins that 
may interfere with the assay. 10 mg/well concentration of 
protein lysates were loaded on a 96 well plate, and the 
assay was carried out as detailed in the kit instructions. 
The enzymatic reaction was stopped after incubation 
using reagent supplied in the kit, and the resulting yellow 
colour was read on a colorimetric microplate reader 
at 405 nm (Anthos HTIII Microplate Reader, Denley 
Instruments, UK). The optical density of the bound colour 
emitted is inversely proportional to the concentration of 
cAMP level in samples, which was calculated according 
to the instructions supplied in the kit. All results were 
analysed by oneway ANOVA with posthoc Dunnett 
tests using the GraphPad Prism 3.02 software. Data was 
generally expressed as mean 6 S.E.M. for individual sets 
of experiments.
Scratch wound assays
Stable COS-7 clones expressing His-Gb3 and His-Gb3s 
subunits were plated onto poly-d-lysine-coated coverslips 
(10 mg/ml).  These were grown to 100% confluence, 
and serum starved for 12hr. Wounds were created by 
scraping the monolayer of cells with a sterile pipette tip 
and culture media was added with or without inhibitors. 
The images of wounds were captured at 5x magnification 
with a Leica DMiRe2 electronic controlled microscope 
immediately after wounding and again 24 h later. Images 
were collected under bright field using an iXonEM +897 
EMCCD camera (ANDOR technologies ltd, USA) and 
visualised using multi-dimensional microscopy software, 
Andor Module iQ Core. The images were subjected to the 
WIMASIS image analysis application that is available 
for use on the Wimasis my Wim platform.  The data is 
presented as cell covered area at noted time points and 
estimates the effects of inhibitors on cell migration. 
Results 
Expression and characterisation of Gβ3s subunit
EBV transformed Gb3 expressing lymphoblastoid cells 
(CC) and Gb3s/Gb3 expressing lymphoblastoid cells 
(TT) were grown in relevant media, harvested and lysed 
to obtain protein lysates. Following processing of the 
lysates for immunoblotting, SDS-PAGE was performed 
and the blot was probed with a custom raised Gb3 specific 
antibody [11]. The fundamental difference between CC 
and TT lymphablastoid cells was the expression of only 
the larger “normal” 340 amino acid long Gb3 protein 
(calculated Mol. Wt. = 37090 Daltons) in the CC cell line 
while the latter, TT cell line expressing approximately 
equal quantities of both the Gb protein and the smaller 299 
amino acid Gb3s protein (calculated Mol. Wt. = 34990 
Daltons) (figure 1a). Protein lysates obtained from COS-
7 clones following stable transfection with either histidine 
(His) tagged Gb3 construct (Gb3-COS) or His tagged Gb3s 
(Gb3s-COS), when probed with anti His antibody, revealed 
similar expression pattern, with His-Gb3s producing a 
lower band when compared to His-Gb3 protein (figure 1b). 
G-proteins are highly expressed in the endomembrane and 
Golgi vesicle compartments and display diffused transport 
kinetics upon stimulation [27]. Following immunostaining 
of Gb3-COS and Gb3s-COS with anti-His antibody, similar 
subcellular expression was observed for Gb3 and Gb3s 
with both showing co-localisation with the co-transfected 
Golgi-YFP (figure 1c-d). 
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It has been known that in culture cells, Gβ and Gγ 
subunits interact to rapidly form the irreversible Gbγ 
dimer following synthesis [29]. Cell periphery staining 
of Gb3 and Gb3s was observed that indicated their 
plasma membrane association along with endogenous 
Gg subunits, expressed as Gbg dimers. This observation 
suggests that our stable clones express the His tagged 
constructs of Gb3 and Gb3s subunit that can efficiently 
form dimer with endogenous Gg, and get processed as 
Gβγ dimer, to traffic between cytosol, Golgi and plasma 
membrane.
Epidermal Growth Factor (EGF)-induced Ca2+ ion 
influx was enhanced in the presence of Gβ3s
Intracellular Ca+ ions are known to be modulated 
following G-Protein Coupled Receptors (GPCRs) 
stimulation via Gβγ [30]. Moreover Gbg signaling and 
Ca2+ mobilisation both co-operate synergistically in the 
activation of JNK by Gq-coupled receptors [30]. Hence, 
we wanted to examine whether stimulation with EGF 
will cause any change in the Ca+ ion influx in our cell 
line models and also whether this Ca+ response will be 
altered due to the presence of Gb3s subunit instead of 
its normal counterpart. To determine this, we exposed 
TT and CC lymphoblastoid cell line models to EGF. 
Growth factor stimulation significantly increased Ca+ ion 
influx in both cell lines (figure 2). However, there was 
significantly greater initial increase in TT cells compared 
to CC cells. Moreover, while there was some degree of 
time dependent fluctuation of Ca+ ion influx, the TT cell 
line sustained this enhanced in flux over the course of 200 
seconds (figure 2). This study indicated Gb3s dependent 
signaling alteration and provided first functional evidence 
in the current investigation that was specific to the Gb3s 
subunit. 
Gβ3s induces ERK activity and activates mTOR 
pathway but not AKT1
MAPK cascades are evolutionarily conserved in regulating 
cell signal transduction by connecting cell-surface receptors 
to critical regulatory targets within cells. These pathways 
are essential in controlling cell survival, proliferation and 
apoptosis. Since both Receptor tyrosine kinases as well 
as GPCRs signal mainly via PI3K and MAPK pathways, 
we wanted to determine whether the presence of Gb3s 
will have any impact on the key effector proteins of 
these pathways. We found that both TT lymphoblastoid 
and Gβ3s-COS cells had significantly higher basal 
levels of ERK phosphorylation (figure 3 a). Probing for 
the presence of phosphorylated AKT1 on the contrary 
revealed a reduction in basal Threonine-308 (T-308) and 
Serine-476 (S-473) AKT1 phosphorylation in both TT 
lymphoblastoid and Gβ3s-COS cells as compared to their 
normal counterparts (figure 3a and 3g). Interestingly, both 
TT lymphoblastoids and Gβ3s-COS also showed enhanced 
mTOR phosphorylation at Serine 2481 (S-2481) despite 
the reduction in AKT1 phosphorylation (figure 3b). This 
prompted us to look at downstream phospho induction of 
mTOR substrates. As shown in figure 3b, enhanced mTOR 
phosphorylation was also accompanied by induction of 
its substrates p70S6K [phospho Threonine 389 (T-389) 
and phospho Serine 371 (S-371)] and 4E-BP1 [phospho 
Threonine 46 (T-46)] indicating hyperactivation of mTOR 
pathway in Gβ3s containing cell lines. 
Previous studies have reported that agonists of GPCRs 
potentiate the mitogenic effect by promoting a sustained 
late phase activation of PI3K and p70S6K via a pathway 
dependent on the Gbg subunits of heterotrimeric G 
proteins [31]. The activation of p70S6K is a critical step in 
ribosomal biosynthesis promoting translational activation 
within a cell [32]. Phosphorylation of particularly S-371 
residue of p70S6K has been shown to be a specific target 
of mTOR in breast cancer cells [33]. Our results suggest 
that in the presence of Gβ3s, there was upregulation of 
p70S6k activity and 4E-BP1 probably in mTOR dependent 
manner but independently of PI3K and AKT, which may 
implicate increased translation in Gβ3s containing cells. 
Gβ3s promotes nuclear accumulation of Foxo3a 
suggesting an increase in its transcriptional activity
AKT activation leads to phosphorylation of Foxo3a that 
results in its exclusion from nucleus and sequestration 
Figure 1. Expression of Gβ3 and Gβ3s subunits. CC and TT 
lymphoblast cell lysates were immuno blotted with custom raised 
GNB3 antibody to determine Gβ3 and Gβ3s protein expression 
levels respectively (a). Protein lysates forming stable COS-7 clones 
were analyzed for the expression of His tagged Gβ3 and Gβ3s 
upon immunoblotting with Anti-Histidine (his) antibody (b). Data 
presented here is of n = 3 independent experiments. No localisation 
difference between His tagged Gβ3s and Gβ3 subunit was observed 
when immune probed with Anti-his in stable clones transfected with 
Golgi-YFP in both untreated and EGF stimulated condition (c-d). 
These images are taken from different fields of view under a 40x 
objective with further 1.5x magnification. 
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in cytoplasm, thereby inhibiting its transcriptional 
function [34]. Since we found downregulation of AKT 
activity in our cell line models, we next asked whether 
this downregulation would also result in reduction of 
phospho Foxo3a, which would then lead to its nuclear 
accumulation allowing it to functions as a transcription 
factor. Also, the fact that we saw elevated p70S6k in the 
presence of the Gβ3s variant, indicating translational 
induction, we wanted to see whether the presence of 
Gβ3s would similarly cause transcriptional induction 
via Foxo3a activity. According to figure 3b, there was a 
significant reduction in phosphorylated levels of Foxo3a 
on Serine 318/321(S-318/321) and Serine 253 (S-253) 
indicating its activation. 
Immunostaining of subcellular Foxo3a revealed that 
Gβ3s induced reduction of phospho Foxo3a also led to an 
increase in its nuclear accumulation in constitutive state 
(figure 3 e & j) as well as following stimulation with EGF 
(figure 3 f & k) in our cell line models. This particular 
nuclear staining appears to be absent in CC lymphoblast 
(figure 3c-d) and Gβ3-COS cells (figure 3h-i) expressing 
normal Gβ3 subunit. These figures suggest that loss of 
AKT phosphorylation in the presence of Gβ3s may lead 
to Foxo3a mediated transcriptional induction and hence 
present an altered signaling profile as compared to cells 
harboring the normal copy of the gene. 
Presence of Gβ3s variant causes downregulation 
of Cyclic AMP and increased phosphorylation of 
Caveolin 1a in response to EGF stimulation
Gbg signaling has been shown to play a role in modulating 
Figure 2. Gβ3s subunit leads to enhanced Ca2+ influx kinetics. 
Intracellular cytosolic Ca2+ influx was quantified using Fluo-4 NW as 
mentioned in materials and methods. Ca2+ quantification assay revealed 
enhanced Ca2+ influx in TT lymphoblast upon EGF stimulation, when 
compared to CC lymphoblast cells. Data presented in all panels are 
the mean with standard error (bars) of n = 3 independent experiments 
performed in octuplets. Statistical significance is shown as *P<0.05, 
**P<0.01, ***P<0.001.
intracellular levels of second messenger, cyclic AMP 
(c-AMP) and its function has been implicated in both 
c-AMP increase [35] and decrease [36]. Furthermore, 
c-AMP was previously found to inhibit MAPK levels via 
its activation of Protein kinase A (PKA) that resulted in 
repression of ERK phosphorylation [37]. This prompted us 
to investigate the effect of Gβ3s on c-AMP levels and also 
determine whether the enhanced ERK phosphorylation 
due the presence of Gβ3s seen in figure 3 (b & g) may also 
be contributed by modulation of c-AMP levels. Following 
treatment with c-AMP inducer Forskolin, higher levels of 
cAMP generation was observed in TT cells as compared 
to CC. Contrastingly, upon EGF stimulation, cAMP levels 
were found to be downregulated in TT lymphoblast cells 
as compared to CC (figure 4a).
Altered cAMP regulation in TT lymphoblastoid cell line 
can implicate differences in various signaling processes 
including differential regulation of the microenvironment 
by recruitment of scaffolding molecules that include 
caveolae [38]. Hence, we next investigated any changes 
in caveolin 1 (Cav 1), an essential component of caveolae, 
which are a subtype of cholesterol-enriched lipid 
microdomains/rafts. Investigation of Cav1 levels were 
based on the following reasons: Firstly, Gbg signaling 
has been shown to modulate caveolae function [39], 
secondly, Foxo3a transcription factor, which in this study 
was found to be stabilized in the nucleus, was previously 
shown to transcriptionally upregulate Cav1 [40] and 
lastly the c-AMP levels, which were shown to drop in 
Gβ3s containing cell lines, were reported to downregulate 
Caveolin-1 expression [41].  
These previous reports as well as insights from current 
investigation led us to propose that the phosphorylated 
levels of pCav1 might be altered in Gβ3s containing 
cells as compared to their normal counterparts. Indeed 
we found that both at basal levels and upon EGF 
stimulation, the levels of phosphorylated Cav1 at 
tyrosine 14 (Y-14) residue in both Gb3s-COS and TT 
lymphoblast cells showed an induction in comparison to 
Gb3-COS and CC lymphoblast cells respectively (figure 
4b) thus confirming our hypothesis. These studies 
also suggest that Gb3s signaling may be involved in 
cytoskeletal remodeling and maintenance of cell shape, 
features that regulate cell migration and metastasis, 
by modulating c-AMP levels that result in changes in 
Caveolae microdomains. 
AKT1 localisation towards caveolar membrane free 
domains is reduced in the presence of Gβ3s subunit
Following the previous finding that Cav1 phosphorylation 
was enhanced in Gb3s containing cells, we next wanted 
to determine at a cellular level whether there is an 
accompanying altered localisation of substrates of PI3K 
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Figure 3. Gβ3s subunit hyper activates ERK overcompensating for the lack of AKT activity. Phospho immuno reactivity of ERK2 
and AKT1 at relevant residues are shown in CC and TT lymphoblast protein extracts (a). TT lymphoblast protein extracts showed 
significant changes in relative phosphorylation activity when compared to CC lymphoblasts in PI3K-AKT pathway substrates such as 
Foxo3a, mTOR, p70S6k and 4E-BP1 at relevant residues (b) which was confirmed by semi quantitative densitometry analyses as described 
in materials and methods. Data presented in all panels are the mean with standard error (bars) of n = 3 independent experiments. Lysates 
from stable COS-7 clones showed similar kinetics in terms of ERK and AKT1 phosphorylation as observed in lymphoblastoid cells 
(g). Statistical significance is shown as *P<0.05, **P<0.01, ***P<0.001. Foxo3a immuno staining of lymphoblast cells was performed 
using total Foxo3a antibody at both basal and EGF stimulated condition as mentioned in methods (c-f). TT lymphoblast cells and Gb3s-
COS7 cell showed distinct nuclear Foxo3a staining. White arrows indicate co-localisation with DAPI (blue) upon EGF stimulation 
confirming nuclear retention (f & k). This particular nuclear staining was not observed in CC lymphoblasts and Gb3-COS cells both in 
untreated (c & h) and EGF stimulated conditions (d & i). Images were taken from different fields of view under a 40x objective with 
further 1.5x magnification. Bar = 13mm.
pathway at caveolae. This was done owing to the fact 
that we had found altered phosphorylated levels of PI3K 
substrates that can lead to a substantial change in their 
sub-cellular compartmentalisation. 
Monitoring the cholera toxin B (CTB) subunit 
internalisation in mammalian cells has previously 
been reported as a marker for uptake via the caveolae-
dependent pathways [39]. We used Fluorescein 
isothiocyanate (FITC) conjugated CTB subunit (FITC-
CTB) to study the localisation of AKT, mTOR and P70S6K 
within caveolae at a single cell level both in Gb3-COS 
and Gb3s-COS cells at basal levels and following EGF 
stimulation. In Gb3-COS cells, we found co-localisation 
of AKT1 with internalized caveolae both in untreated 
states and following EGF stimulation (figure 5a, a’, 
b & b’). Interestingly, this co-localisation of AKT1 
and caveolae was disrupted in Gb3s-COS cells both in 
untreated and following EGF stimulated states (figure 5 c, 
c’, d, d’). This suggested that reduced levels of phospho 
AKT1 found in Gb3s caused mislocalisation and failure 
of total AKT levels to localise with internalized caveolae. 
This finding led us to extend our cell staining study and 
investigate whether the enhanced phosphorylated forms 
of mTOR and P70S6K observed in Gb3s containing cells 
would cause their increased localisation with caveolae. 
Immunostaining of mTOR and P70S6K in individual 
cells and their co-localisation with FITC-CTB revealed 
enhanced co-localisation between the two in untreated 
Gb3s-COS cells and exhibited a further induction 
following EGF stimulation (figure 5 g’ and h’ for mTOR 
staining and k’ and l’ for  P70S6K). On the other hand, Gb3-
COS cells exhibited such co-localisation only following 
EGF stimulation and failed to show any co-localisation in 
unstimulated condition (figure 5 e’ and f’ for mTOR and i’ 
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Figure 4. Lack of cAMP induces caveolar-1a phosphorylation. cAMP analysis was measured  in CC and TT 
lymphoblast protein lysates obtained from either untreated cells, or following treatments with EGF or Forskolin (Fsk) 
as mentioned in methods (a). Decrease in cAMP generation upon EGF stimulation in TT lymphoblast leads to increased 
phosphorylation of Cav -1a when compared to CC lymphoblast cells (b). Similar trend in cav-1a phosphorylation 
kinetics was observed in COS-7 stable clones. Data are the mean with standard error (bars) of n=3 independent 
experiments. Statistical significance is shown as *P<0.05, **P<0.01, ***P<0.001.
and j’ for P70S6K). This difference between Gb3 and Gb3s 
mediated signaling could have important implications. 
PI3K is an upstream activator of AKT that operates by 
recruiting AKT to cellular membranes via the pleckstrin 
homology membrane-binding domain of AKT. It has been 
shown that membrane-microdomain compartmentalisation 
is critical for maintaining proper PI3K/AKT signaling in 
response to insulin and dysregulating raft-localised PI3K/
AKT signaling [42]. Lack of AKT1 at the membrane in 
Gb3s-COS cells implies that the decrease in activation 
of AKT1 (figure 3a & 3g) might have affected its 
membrane-binding dynamics resulting in the absence of 
a fully functional AKT1at the cell membrane (figure 5 c’ 
& d’). On the other hand, increased signaling activity and 
localisation of mTOR, p70S6K but not AKT1 to caveolae 
structures (figure 6 g’ & h’) suggests that Gb3s subunit 
signaling primarily uses caveolae as localised signaling 
domains that may promote cytoskeletal remodeling 
and actin reorganisation, features that may induce cell 
migration and metastatic behavior. 
Gβ3s subunit localises in and enhances actin stress 
fibers formation
The cell cytoskeleton is a network of structural fibers 
found within the cytoplasm of a cell. It is responsible for 
cell movement and shape stability. Actin microfilaments 
are one of the three major types of fibers that form the 
cell cytoskeleton. Through their association with motor 
proteins such as myosin, actin microfilaments carry 
out cellular movements [43]. Discoveries made in the 
previous section i.e. Cav1 Y-14 phosphorylation was 
induced in Gb3s cells both in basal and EGF stimulated 
states as well as the localisational differences of AKT, 
mTOR and p70S6K with caveolae between Gb3 and Gb3s 
expressing cells, prompted us to study any changes in 
the cell cytoskeleton in cells carrying Gb3s subunit. 
Investigating cytoskeletal changes were also based on 
the fact that Cav-1 was found to be associated with actin 
fibers through induction of cross-linking of filamin protein 
[44]. Additionally, Gbg signaling is known to activate 
PAK1/PIX alpha/Cdc42 pathway for the localisation of 
F-actin at leading edge of cell for directional sensing, 
and the persistent directional migration of chemotactic 
leukocytes [45]. We found that following fluorophore 
conjugated phalloidin staining and counting the number 
of F-actin fibers per cell, Gb3s-COS cells displayed 
enhanced basal as well as EGF induced F-actin stress fiber 
formation as compared to normal Gb3-COS cells (figure 
6 a-e). Moreover, immunolabelling of phalloidin-stained 
Gb3-COS and Gb3s-COS cells with anti His antibody 
revealed enhanced co-localisation between Gb3s and 
actin stress fibers both at basal and EGF induced states 
as compared to cells with Gb3 (figure 6 f-i). This implies 
that Gb3s subunit may participate in F-actin filament 
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assembly and formation of stress fibers not just by down 
regulation of c-AMP and upregulation of Foxo3a leading 
to activation of Cav1a as illustrated in previous sections, 
but also via direct binding to actin filaments that may 
recruit scaffolding and structural proteins with enhanced 
kinetics. 
Actin reorganisation and modeling, which is a key 
element in cell migration, has previously been shown 
to be in part dependent on PI3K and Ras pathway, 
independent of GPCRs, where PI3K was found to localise 
at sites of F-actin projection [46]. Recently, regulation of 
F-actin assembly was also reported in PI3K independent 
but AKT dependent manner [47] while earlier reports 
have demonstrated that activation of P70S6K alone was 
sufficient for F-Actin remodeling and cell migration even 
in the presence of PI3K inhibitors [48].  Since in the 
presence of Gb3s, phosphorylated levels of AKT1 were 
downregulated even though cells exhibited F-actin stress 
fiber formation, we next asked whether the upregulated 
Figure 5. Gβ3s containing cells exhibit enhanced co-localisation of mTOR and p70S6K with caveolae while mislocalisation 
of AKT. Cholera toxin B (CTB) subunit uptake studies were performed in Gb3-COS and Gb3s-COS cells upon EGF 
stimulation. Cells were treated with CTB for 2 hr and stimulated with EGF, fixed and co-immunostained with AKT, mTOR and 
p70S6K antibodies and secondary antibodies conjugated to Alexa Flour 568. Gb3s-COS cells lack co-localisation of AKT with 
CTB-FITC (c & d with highlighted boxes shown as c’ & d’) denoted by arrowheads when compared to Gb3-COS (a & b with 
highlighted boxes shown as a’ & d’). Immunostaining of mTOR and p70S6K revealed co-localisation with CTB-FITC both in 
untreated (g’ & k’) and EGF stimulated (h’ & l’) in Gb3s-COS while only in EGF stimulated states in Gb3-COS cells (compare 
e’ and  i’ with f & j). Images were taken from different fields of view under a 40x objective with further 1.5x magnification. 
Bar = 13mm, bar in highlighted box=3µm. 
levels of mTOR and P70S6K were localised at the F-actin 
assembly in the Gb3s cells and hence implicate their 
involvement in cytoskeletal remodeling in the absence 
of any phospho ATK.  We found that AKT1 failed to 
co-localise with F-actin stress fibers in the EGF treated 
Gb3s-COS cells (figure 7, compare a & b with c & 
d).  Interestingly, enhanced co-localisation of mTOR 
and p70S6K within F-actin stress fibers was observed in 
Gb3s-COS cells (figure 7g, h, k & i) when compared to 
Gb3-COS (figure 7e, f, j & l).  This suggests that these 
molecules interact specifically within the stress fiber 
region to regulate cytoskeletal remodeling and perhaps 
alter cell motility. 
The altered localisation of total AKT in Gb3s-COS 
cells at both basal and EGF stimulated conditions 
indicate that the reduced AKT S-473 and T-308 
phosphorylation in TT lymphoblast and Gb3s-COS 
cells (figure 2a & 3g), impaired its co-localisation with 
actin filament assembly.
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Figure 6. Gβ3s subunit co-localises with F-actin and enhances actin stress fiber formation. Gb3-COS and Gb3s-
COS cells were either left untreated or treated with EGF followed by F-actin staining using Alexa fluor 568 conjugated 
phalloidin. Gb3s-COS cells exhibit enhanced stress fiber formation (white arrow heads) both in untreated (c) and EGF 
stimulated (d) when compared to Gb3-COS untreated (a) and EGF stimulated (b). The number of cells exhibiting stress 
fiber formation were counted as mentioned in material and methods and plotted as graph to represent % of stress fiber 
forming Gb3s-COS and Gb3-COS cells (e). Increased Anti-His staining and co-localisation within F-actin stress fibers 
(arrow heads) is observed in HA-Gb3s-COS cells both in basal (h) and EGF treated states (i) when compared to anti 
His staining of HA-Gb3-COS (f, g). Images were taken from different fields of view under a 40x objective with further 
1.5x magnification. Bar = 13mm.
Presence of Gβ3s variant enhances cell migration and 
scratch wound healing
A number of findings made in our investigation 
uncovered signaling alteration specific to the presence of 
Gb3s not only in PI3K and MAPK pathway substrates, 
but also in second messengers and overall cytoskeletal 
remodeling. Cav-1 expression and phosphorylation is 
known to be associated with enhanced cell migration 
especially in fibroblasts, where caveolin-1 expression 
and phosphorylation at Y-14 residue are proven to be 
essential to promote migration [49]. Moreover activation 
of p70S6K leads to expression and proteolytic activity of 
matrix metalloproteinase (MMP)-9 and cellular invasion 
in ovarian cancer cells [50]. Finally, we found greater 
nuclear retention of Foxo3a, which was previously found 
to induce MMP-9 and MMP-13 expression resulting in 
increased cancer cell invasion [51]. Therefore, enhanced 
Ca+2 influx coupled with ERK hyperphosphorylation 
following growth factor stimulation, with overall increase 
in nuclear Foxo3a abundance, Cav1 phosphorylation and 
formation of actin stress fibers prompted us to investigate 
whether Gb3s specific signaling profile would lead to 
enhanced cell migration. 
To answer this, we studied cell migration by 
performing boyden chamber based migration assays 
using different migratory and Ca2+ stimulating ligands 
on Gb3s/Gb3 expressing TT lymphoblastoids and only 
Gb3 expressing CC lymphoblastoid cells. We found that 
TT lymphoblastoid cells under control (BSA stimulated) 
conditions had a significantly larger number of migrating 
cells than CC cells (figure 8a). Moreover, following ligand 
stimulation by EGF, Vascular Endothelial Growth Factor 
(VEGF) and Transforming Growth Factor a (TGFa), the 
number of migrating cells increased for both CC and TT 
cell types (figure 8a). However, upon ligand stimulation, 
the latter cell type showed a significantly greater number 
of migratory cells than the former, especially for EGF 
treatment, which led to almost twice the number of motile 
TT cells as compared to CC (figure 8a). The migratory 
difference following EGF stimulation is also displayed 
as a % change from the basal rate, normalized to 100% 
for both CC and TT cell types (figure 8b). According to 
this figure, following stimulation with ligand, the % of 
migrated cells doubled in TT cells, as compared to CC 
cells where only a modest increase was observed. 
In a similar experiment, scratch wound healing assays 
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on stable COS7 clones of Gb3 and Gb3s was performed. 
Scratch wound healing assay revealed enhanced kinetics 
of wound healing of Gb3s-COS cells (figure 8f & g) as 
compared to Gb3-COS cells (figure 8d & e) 24hrs post 
scratch and stimulation with EGF. The enhanced surface 
area covered by Gb3s-COS when compared to Gb3-COS 
post scratching reveals that Gb3s subunit expression 
(figure 8f) induced enhanced migration kinetics, but not 
cell proliferation (figure 1a & b).
Taken together, these findings suggest that lower 
comparative activation of AKT1, but enhanced mTOR 
and downstream substrate phosphorylation suggest that 
a second regulatory pathway responds to growth factor 
stimulation only in the presence of the Gb3s subunit to 
promote enhanced migration. 
Gβ3s-induced cell migration is dependent upon Ca2+ 
influx-regulated ERK but independent of AKT1 and 
mTOR 
Gbg effector signalling is primarily regulated through 
Ca+2 ion flux, which in turn activates various signaling 
Figure 7. Gβ3s subunit displaces AKT away from actin stress fibers. F-actin staining using Alexa fluor 568 
conjugated phalloidin and co-immuno staining using antibodies against total AKT1, mTOR and p70S6k and subsequent 
relevant secondary antibody conjugated to alexafluor-488 was performed for both Gb3-COS and Gb3s-COS cells (a-i). 
While Gb3-COS exhibit co-localisation between F-actin and AKT1, Gb3s-COS cells fail to show such co-localisation 
both in untreated and EGF treated states (compare a & b with c & d). Gb3s-COS cells exhibit enhanced co-localisation 
of mTOR and p70S6K with F-Actin stress fibers as compared to Gb3-COS cells (compare g, h, k & l with e, f I & j 
respectively). Images are representative of several images taken from different fields of view under 40x objective with 
further 1.5x magnification. Bar = 13mm. Data are the mean with standard error (bars) of n=3 independent experiments 
(n). Statistical significance is shown as *P<0.05, **P<0.01, ***P<0.001. 
pathways that control cell migration [6]. Gbg stimulates 
Ca2+ ion influx from the extracellular space, leading to 
the activation of calmodulin and inactivation of the IP3 
receptor. In order to dissect and identify the signaling 
pathways regulated by Gb3s subunit in inducing enhanced 
cell migration as shown here, we individually targeted 
different components of pathways downstream of Gbg 
signaling and studied its effect on phosphorylational 
induction of key substrates, dynamic changes in Ca2+ 
ion fluxes and their consequences for cell migration and 
scratch wound healing. 
First of all, in order to characterize the role of Ca2+ 
ion flux in Gb3s induced migration, we blocked the 
calcium channels using verapamil, an L-type calcium 
channel blocker. We saw inhibition of EGF stimulated 
intracellular Ca2+ ion influx following verapamil treatment 
in both TT and CC cells. However, this inhibition was to 
a lesser extent in TT lymphoblasts as compared to the CC 
counterparts (figure 9a). Interestingly, verapamil treatment 
led to increased AKT1 phosphorylation at both T-308 and 
S-473 residues in CC and TT cells (figure 10a & c) as 
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compared to untreated cells (figure 3b). As expected, this 
AKT1 activation also led to a corresponding increase in 
Foxo3a phosphorylation in EGF stimulated cells following 
Verapamil treatment (figure 11a). To confirm the role of 
Ca2+ ion influx in regulating ERK activation, we blotted 
for total and phospho ERK and found that upon Ca2+ influx 
inhibition, phospho ERK levels dropped and the degree 
of reduction of ERK activity corresponded well with the 
degree of Ca2+ ion inhibition achieved with verapamil in 
the CC and TT cell line models (10 a & b). This confirmed 
the earlier assumption that EGF stimulated ERK induction 
is as a result of enhanced cytosolic Ca2+ ion influx in Gb3s 
containing cells. Moreover, while the phosphorylated 
levels of mTOR and 4E-BP1 showed a decrease upon 
inhibition of Ca2+ influx (figure 11c & e), there was an 
overall increase in p70S6K T-389 phosphorylation (figure 
11d) in TT cells as compared to the CC counterparts. 
Figure 8. The presence of Gβ3s subunit enhances cell migration. CC and TT lymphoblastoids were either left 
untreated, or treated with growth factors and subjected to boyden chamber based chemotactic migration assay to 
examine their relative differences in migration. EGF, TGFa and VEGF stimulated enhanced chemotactic migration 
of serum starved TT lymphoblast cells as compared to CC (a). Control refers to 5% BSA stimulation in both CC 
and TT lymphoblast cells.  The percentage of cell migration upon EGF stimulation is high in TT when compared 
to CC (b). Data presented in all panels are the mean with standard error (bars) of n = 3 independent experiments 
performed in octuplets. Statistical significance is shown as * P<0.05, **P<0.01, ***P<0.001. For scratch wound assays 
(c-g), scratches were made with a fine tip on coverslips containing stable clonal adherent Gb3 and Gb3s COS-7 cell 
lines. COS-7 stable clone expressing Gb3s subunit showed greater gap closure 24hr post scratching (c & d) when 
compared to COS-7 stable clones expressing normal Gb3 subunit (e & f). Graphical representation of % area covered 
by cells following 24hr of wound healing (h). These images are taken from different fields of view under a 5x objective 
with further 1.5x magnification. Bar = 100mm. WIMASIS analysis tool was used to measure area covered by cells as 
mentioned in the methods section (e). Data presented in all panels are the mean with the standard error (bars) of n = 3 
independent experiments. Statistical significance is shown as *P<0.05, **P<0.01, ***P<0.001. 
In Rat-1 fibroblasts, phosphorylation of 4E-BP1 was 
shown to occur via a pathway that was Ca2+ and calmodulin 
dependent [52]. Intracellular Ca2+ ions were also shown 
to induce p70S6k phosphorylation upon ionomycin or 
thapsigargin treatment independent of AKT1in Balb/c-
3T3 fibroblasts [53]. Since there was a decrease in Ca2+ 
influx following verapamil treatment in EGF stimulated 
cells (figure 9a), the increase in p70S6k phosphorylation 
(figure 11d) following this treatment in Gb3s cells could 
be independent of Ca2+. As there was AKT1 activation, 
this upregulation of p70S6k phosphorylation could have 
resulted from AKT1. Overall, we found that inhibition 
of Ca2+ influx reduced ERK, mTOR and 4E-BP1, but 
increased ATK1 and p70S6k phosphorylation. 
We next studied the effects of MEK inhibition on these 
signaling components. Targeting MEK in the Ras/Raf/
MEK/ERK pathway is advantageous as it is a convergence 
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point for upstream signaling pathways controlled by AKT 
and ERK. ERK is known to be activated by MEK in a 
calcium sensitive pathway also involving modulation by 
cAMP via PKA. We found maximum inhibition of EGF 
induced cytosolic Ca2+ influx upon treatment with U0216, 
a MEK inhibitor (figure 9c). This correlates well with 
inhibition of ERK phosphorylation as expected (figure 
10a). 
Treatment of U0216 resulted in modest induction of 
AKT phosphorylation at both T-308 and S-473 residues in 
CC and TT lymphoblasts (figure 10a & d) when compared 
to untreated cells (figure 3b). A significant decrease in 
phospho 4E-BP1 threonine-46 residue was observed 
(figure 11a & e) upon MEK inhibition even though there 
was activation of mTOR and p70S6K (figure 11a, c & d). 
This suggests that the mTOR pathway activation via MEK 
inhibition might not involve a protein translation function. 
Previous studies reported the participation of Raf-1/MEK/
ERK in crosstalk with 4E-BP1, leading to increased protein 
synthesis, cell growth, and kidney tumor formation (54). 
The drop in 4E-BP1 phosphorylation observed here or 
alternatively its activation (figure 3b) corresponded well 
with ERK activity rather than mTOR>p70S6k activation in 
both CC and TT lymphoblast cells (figures 10 & 11). 
Next, in order to directly target upstream signaling 
emerging from G proteins, we used a GRK2 polypeptide 
(GRK2i), which acts as a cellular Gβγ antagonist by 
inhibiting binding to Gbg dimer and sequester its signaling 
activity [55]. Following GRK2i treatment of both CC 
and TT lymphoblastoids, there was a modest decrease of 
EGF stimulated cytosolic Ca+2 ion influx in TT cells and 
complete inhibition in CC counterparts (figure 9b). GRK2i 
treatment also caused a significant decrease in ERK 
phosphorylation CC lymphoblastoids, while to a lesser 
extend in the Gb3s containing TT counterparts (figure 
10a & b). Moreover, while phospho AKT at S-473 was 
Figure 9. Cytosolic Ca2+ influx in Gβ3s containing cells responds differently to growth signaling inhibitors. CC and TT cells were exposed 
to a co-treatment of Gβγ signaling inhibitors and EGF and in parallel, temporal changes in intracellular cytosolic Ca2+ influx were quantified 
by employing Fluo-4 NW based Ca2+ assay as mentioned in materials and methods. Treatments with calcium ion channel blocker Verapamil, 
Gbg signaling inhibitor GRK2i, and MEK inhibitor U0216 caused decrease in EGF induced cytosolic Ca2+ levels (a, b and c respectively) 
in both TT and CC lymphoblast cells, however, EGF induced Ca2+ levels in TT lymphoblasts were more resistant to inhibitors than the CC 
counterparts. Inhibition of MAPK pathway by way of using MEK inhibitor U0216 was found to be most potent in inhibiting cytosolic Ca2+ ions 
in TT lymphoblast cells. Data presented in all panels are the mean with a standard error (bars) of n = 3 independent experiments performed in 
octuplets. Statistical significance is shown as *P<0.05, **P<0.01, ***P<0.001.
inhibited, AKT phosphorylation at T-308 (figure 10a & c) 
and mTOR S-2481 (figure 11a & c) were still maintained. 
Only partial inhibition of ERK phosphorylation in GRK2i 
treated Gb3s containing cells as compared to their Gb3 
counterparts could be based on the fact that following 
this treatment, there was still sufficient cytosolic calcium 
influx upon EGF treatment in TT cells as compared to CC 
where a complete inhibition was seen (figure 9b). 
We finally studied the effects of the above treatments 
on cell migration of TT and CC cells, kinetics of scratch 
wound healing in Gb3-COS and Gb3s-COS cells and 
actin stress fiber formation. We found that inhibition 
of cytosolic Ca2+ influx following verapamil treatment 
inhibited EGF induced migration of TT lymphoblast cells 
down to their untreated levels (figure 12a). This implied 
the involvement of Ca2+ dependent activation of ERK in 
the enhanced migration of Gb3s cells as well as an AKT 
independent phenomenon. This further suggests that Gbg 
signaling induces hyper Ca2+ influx, which primarily 
contributes to the activation of ERK and mTOR activity, 
leading to enhanced migration only in the presence of a 
Gb3s subunit but not in its absence. In a similar experiment, 
we found that the kinetics of wound healing in Gb3s-COS 
were also significantly reduced upon verapamil treatment 
(compare figure 2e & f with figure 13g & h) also probably 
explaining the absence of EGF induced actin stress fiber 
formation following such treatments (compare figures 6d 
& 13x). 
Hence, the elevation of AKT T-308 residue 
phosphorylation upon Verapamil treatment was not 
sufficient to potentiate migration kinetics in both the CC 
and TT lymphoblast cells (figure 12a) and COS7 stable 
clones (figure 13 a, b & g, h & 12 m, n). This implied 
that at signal effector level, the involvement of ERK 
was critical for the enhanced Gb3s migration. Indeed, 
when the MEK inhibitor, U0216 was employed, which 
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Figure 10. The presence of Gβ3s causes altered ERK and AKT signaling response to growth inhibitory treatments: TT and CC 
lymphoblasts were exposed individually to calcium ion channel blocker Verapamil, Gbg signaling inhibitor GRK2i, and MEK inhibitor 
U0216 to study the effects of such treatments on their EGF induced phospho ERK and AKT1 signaling profiles. While EGF induced 
ERK phosphorylation was disrupted in TT lymphoblasts following treatments with any of the inhibitors with most inhibition achieved 
following MEK inhibition (a & b), phospho AKT1 Serine 473 levels were found to be enhanced upon verapamil treatment in TT cells 
as compared to CC counterparts (d). Distinct responses to inhibitor treatments as exhibited by TT and CC lymphoblasts are confirmed 
by semi quantitative densitometry analyses. Data presented in all panels are the mean with standard error (bars) of n = 3 independent 
experiments. Statistical significance is shown as *P<0.05, **P<0.01, ***P<0.001. 
Figure 11. Inhibition of EGF-induced mTOR, 4E-BP1, p70S6K and Foxo3a signalling in TT and CC lymphoblasts exhibit 
distinct responses. Phospho immunoreactivity of mTOR, 4E-BP1, p70S6K and Foxo3a upon treatment with Gbg signaling inhibitors 
shows altered signaling response in TT cells in comparison to CC lymphoblasts. The distinct signaling profiles are confirmed by 
semi quantitative densitometry analyses. Data presented in all panels are the mean with standard error (bars) of n = 3 independent 
experiments. Statistical significance is shown as *P<0.05, **P<0.01, ***P<0.001.
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as expected, inhibited phospho ERK levels, not only 
abrogated cytosolic Ca2+ levels (figure 9c), but also 
resulted in complete inhibition of enhanced cell migration 
of TT cells (figure 12c), closer to 0% closure of the 
scratched surface after 24hr of healing time (figure 13i & 
j) and absence of any stress fiber formation (figure 13y). 
Treatment with GRK2i could not completely inhibit the 
EGF induced enhanced migration of Gb3s cells (figure 
12b) and there was some degree of scratch wound healing 
(figure 13 k & l). Failure of GRK2 inhibition to exert 
complete disruption of migration could be because it 
could not completely prevent EGF induced Ca2+ influx 
(figure 9b), or phospho ERK induction (figure 10b). 
Altogether, these results indicate hyperactivation of a 
signaling pathway that is unique to the presence Gb3s, 
which provide for a mechanism of enhanced migratory 
phenotype exhibited only by cells containing the Gb3s 
variant and not normal Gb3 protein. According to 
this mechanism, EGF stimulation leads to induction 
of supranormal levels of cytosolic Ca2+ that activate 
and cross-talk with MAPK pathway resulting in 
hyperphosphorylated ERK. The low levels of cAMP 
and phospho AKT in Gb3s containing cells also 
result in activation of Foxo3a transcription factor and 
phosphorylation of Cav1 caveolae protein that contribute 
in cytoskeletal remodeling, formation of actin stress fibers 
and enhanced migration upon growth factor stimulation.
 
Gβ3s subunit signaling leads to Rho, Rac, and cdc-42 
GTPases activation
Members of the Rho family of small guanosine 
triphosphatases have emerged as key regulators of the 
actin cytoskeleton, through their interaction with multiple 
target proteins [56]. Moreover, Ca2+ influx plays a major 
role in RhoA activation and in linkage of the RhoA/stress 
fiber cascade to the focal adhesion kinase pathway [57]. 
Rac activation was previously reported to involve Cav1 
Y-14 phosphorylation in mouse melanoma cells [49] while 
Cav1 phosphorylation was also demonstrated to influence 
RhoA, RhoB and RhoC and its downstream effector, 
ROCK in order to promote cell migration and invasion 
[58]. Similarly, Rac2 and CDC42 were found to be 
required for actin assembly to drive cellular translocation 
[58] while inhibition of ROCK reduced metastasis in vivo 
[59]. Thus the cytoskeletal remodeling involving actin 
stress fiber formation, Cav1 phosphorylation and the 
enhanced migration observed in Gb3s containing cells led 
us to investigate if the Rho, Rac and CDC-42 GTPases 
regulation is also altered because of the presence of Gb3s 
subunit. 
To our surprise, in Gb3s subunit expressing TT 
lymphoblasts, we observed enhanced Rho A expression 
and also increase in phosphorylation activity of RhoA 
and Rac1-2-3/CDC-42 at S-71/73 respectively (figure 
14a). TT lymphoblast cells showed decreased expression 
of Rho A when treated with verapamil in comparison to 
treatments with other inhibitor (figure 14b). Hence, Rho 
A expression showed correlation with cytosolic Ca2+ ions 
(figure 2). The enhanced RhoA expression and activity in 
Gb3s-COS cells appeared to localise in actin stress fibers 
at both basal and EGF stimulated conditions (figure 14g, i 
& m & o) in comparison to the RhoA expression in Gb3-
COS cells (figure 14d, f & j & l).
Discussion
This study reports interesting findings of Gb3s subunit 
signaling in regulating and stimulating distinct molecular 
Figure 12. Gβ3s-induced enhance cell migration is blocked by ERK or Ca2+ ion channel inhibition confirming that Gβ3s 
associated migration is a Ca2+ regulated phenomenon. Boyden chamber assay on serum starved CC and TT lymphoblast cells was 
performed to study the effect of Gbg signaling inhibitors on EGF stimulated chemotactic migration. Control is represented as 100% 
migration and refers to 5% BSA stimulation in both CC and TT lymphoblast cells. While ERK and Ca2+ ion channel inhibition caused 
complete disruption of EGF-stimulated enhanced migration of TT cells, GRK2i inhibition only caused partial inhibition of growth 
factor induced migration. Data presented in all panels are the mean with standard error (bars) of n = 3 independent experiments 
performed in octuplets. Statistical significance is shown as *P<0.05, **P<0.01, ***P<0.001. 
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dynamics affecting AKT and ERK activation. This occurs 
through the induction of cytosolic Ca2+ influx activating 
ERK, mTOR and p70S6K leading to reorganisation of actin 
cytoskeleton to enhance cell migration. 
We observed hyper induction of cytosolic Ca2+ 
ions in response to EGF stimulation only in Gb3s 
subunit expressing cells (figure 2). The rise in cytosolic 
calcium is likely to activate classical isoforms of protein 
kinase C (PKC), which moves from the cytosol to the 
membrane, where it is further activated by DAG [60]. 
In aortic endothelial cells, during arteriogenesis of mice 
and zebrafish, suppression of the PI3K/AKT signaling 
pathway resulted in an increased activation of ERK1/2 
[61]. This suggests that the activation of ERK1/2 in the 
TT lymphoblasts may be a compensatory mechanism for 
the loss of PI3K/AKT pathway activity. Ca2+ influx plays 
a crucial role as key mediator of intracellular signaling 
regulated by the Gbg pathways, which in turn control 
various biochemical events. Hyper regulation of calcium 
has previously been shown to increase the rate of PLCβ 
enzyme catalysis, which in turn leads to the production 
of IP3. In H9c2 cells, overexpression of calreticulin 
triggered calcium influx that reduced AKT activation via 
protein phosphates 2A and increased cell susceptibility to 
apoptosis [62]. Long-term elevation of calcium stimulated 
through thapsigargin in H9c2 cells were also reported 
to suppress AKT activity while long term reduction of 
calcium recovered AKT activity [63].  While it is now 
known that ERK is primarily activated by growth factors 
such as EGF by either Ras-dependent or Ras-independent 
pathways leading to activation of the Raf/MEK/ERK 
cascade, how EGF affects gene expression that alters cell 
migration and motility remains largely unknown. One 
study reported that EGF stimulation of fibroblast motility 
is dependent on hyaluronan synthesis [64].
G proteins regulate AKT1 by two distinct and 
potentially opposing mechanisms.  These are by activation 
through Gβγ dimers in a PI3k dependent fashion and 
Figure 13. Disruption of Actin stress fiber formation inhibits cell migration. The degree of wound gap closure was studied 
in Gb3-COS and Gb3s-COS cells by scratch wound assay (c-l) for which, scratches were made with a fine tip on coverslips 
containing stable clonal adherent Gb3 and Gb3s-COS cell lines. Scratch wound healing assay revealed greater decrease in 
gap closure following verapamil (g & h) and U0216 (i & j) treatment while to a lesser extent, following GRK2i treatment 
(k & l) in Gb3s-COS cell line. Gap closure in Gb3-COS cell was sensitive to all inhibitor treatments (a-f). This indicated 
the involvement of Ca+2 ions and ERK pathway in the enhanced scratch wound healing kinetics of Gb3s-COS cell line. 
Images are taken from different fields of view under a 5x objective with further 1.5x magnification. Bar = 100mm. Graphical 
representation of the cell covered area as analyzed by WIMASIS tool as mentioned in materials and methods section (m-n). 
Data presented in all panels are the mean with standard error (bars) of n = 3 independent experiments. Statistical significance 
is shown as *P<0.05, **P<0.01, ***P<0.001. Actin stress fiber formation was inhibited following Gbg signaling inhibition 
indicating the involvement of stress fiber formation for enhanced cell migration of Gb3s cells. While inhibitor treatments 
caused total disruption of EGF induced stress fibers in Gb3-COS cells (o-t), Gb3s-COS cells still retained some actin stress 
fibers following GRK2i treatment (indicated arrow heads) (z) indicating only partial inhibition of migration. The images are 
taken from different fields of view under 40x objective with further 1.5x magnification. Bar = 13mm.
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inhibition mediated by Gaq. Hence AKT1 is considered as 
a novel point of convergence between disparate signaling 
pathways. AKT1 serves as a multifaceted intermediary 
signaling to the diversified downstream biological 
effectors and as such has received much attention for the 
versatile roles it plays in various biological processes. 
Therefore the activation of AKT substrates such as 
mTOR (figure 3b) in the absence of AKT activation itself 
is a consequence of cross talk probably due to high ERK 
phosphorylation (figure 3a) resulting from the signaling 
unique to the presence of the Gb3s subunit. Reduction 
of AKT1 T-308 phosphorylation in TT lymphoblast cells 
(figure 3a) might suggest that in the presence of Gb3s, 
the targets of AKT1 phosphorylation (T-308) such as 
GSK3a/β, Foxo transcription factors, Bad, p21Cip1, and 
p27Kip1 will be affected. Enhanced phosphorylation 
of mTOR, p70S6K and ERK in the absence of AKT1 
activation in TT lymphoblast cells suggests that the 
effectors of AKT1 might be redirected for control through 
ERK to compensate for the lack of AKT1 signaling. 
Phosphorylation of PI3K results in the conversion of 
PIP2 to PIP3. PIP3-triggered translocation of AKT1 from 
the cytoplasm to the plasma membrane is a prerequisite 
for its phosphorylation and activation [65]. In addition to 
altered phosphorylation of AKT1, we also saw distinct 
translocation kinetics of AKT1 in Gb3s-COS cells (figure 
5 & 7). 
Recent studies have also shown that the AKT2 isoform 
is an enhancer of cell migration and invasion in vitro and 
in vivo, and the related AKT1 isoform may function as 
an inhibitor of these metastatic phenotypes [66-68]. 
Moreover it has been identified that treatment with 
Migration Stimulating Factor (MSF), a truncated form of 
fibronectin promotes the migration in human fibroblasts 
and endothelial cells, upon inhibiting AKT activity [69]. 
Thus, downregulation of AKT1 phosphorylation through 
Gb3s signaling seems to be important for the enhanced 
migratory phenotype. 
The observed signaling alterations unique to the 
presence of Gβ3s could exhibit a distinctive translational 
control. Firstly, Foxo3a is a key regulator of ubiquitin 
mediated proteolysis [70], which suggests that there is an 
increased rate of protein breakdown in TT lymphoblasts 
owing to increased Foxo3a stability (reduced 
phosphoFoxo3a) as compared to CC counterparts 
(figure 3b & c). This would lead to higher turn over of 
proteins and increase in amino acid availability. Calcium 
inhibition upon verapamil treatment, on the other hand, 
resulted in reduction of EGF mediated Foxo3a stability 
(increased phosphorylation) in TT cells (figure 11a & 
b). Therefore Foxo3a stability appeared to be regulated 
by cytosolic calcium ions perhaps through its effects on 
Figure 14. Contribution of RhoA in Gβ3s subunit specific cell migration phenotype. Immuno reactivity of total RhoA, 
RhoB, RhoC, Rac 1-2-3 and CDC42 and phospho immuno reactivity of Rho A at S-73 and Rac 1-2-3, cdc42 at S-71 upon 
EGF stimulation were determined by western blotting. TT lymphoblast lysates showed enhanced total RhoA expression 
and RhoA/Rac 1-2-3/cdc-42 activity when compared to normal CC (a). Rho A expression was analysed in CC and TT 
lymphoblast cell lysates upon stimulation with EGF in the presence of inhibitors (b). Data presented in all panels are the 
mean with standard error (bars) of n = 3 independent experiments. Statistical significance is shown as *P<0.05, **P<0.01, 
***P<0.001. Gb3s-COS cells showed enhanced co-localisation of RhoA (g-i) and phosphorylated RhoA, Rac 1-2-3 and 
CDC42 (m-o) with actin stress fibers. The images are taken from different fields of view under 40x objective with further 
1.5x magnification. Bar = 13mm.
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AKT1 phosphorylation. Secondly, in our study we found 
that Gβ3s cells exhibited increased phospho 4E-BP1 
while inhibition of the elevated Ca+2 ions in Gβ3s cells 
led to inhibition of phospho4E-BP1. In hippocampal 
neurons, ERK1/2 has been shown to control 4EBP-1 
phosphorylation [71]. We found that inhibition of the 
hyperphosphorylated ERK1/2 following MEK inhibition 
resulted in a similar reduction of phospho 4E-BP1 levels 
as well.  Thirdly, amino acid availability due to increased 
protein breakdown will also result in mTOR activation 
as mTOR has been shown to be directly activated 
by intracellular amino acid concentration [72, 73]. 
Consistent with this, we found 2-fold increase in mTOR 
phosphorylation in TT cells as compared to CC cells. 
Finally, we also found increased p70S6K phosphorylation 
in TT cells (figure 3b).
In adult cardiomyocytes, tissue plasminogen activator 
was shown to activate p70S6K in a non-AKT dependent 
manner through c-Raf/ERK1/2 pathway [74]. ERK1/2 
was also found to form a complex with p70S6K, suggesting 
ERK1/2 to be the main kinase for p70S6K phosphorylation 
at one or more amino acid residues [75], while 
phosphorylated p70S6K is known to primarily control actin 
cytoskeleton dynamics through involvement of F-actin 
micro domain signaling, stress fiber disruption and 
directional migration of cells [76, 77]. These examples 
indicate a cross-talk mechanism operating between 
mTOR and ERK1/2 pathways in TT lymphoblast cells 
leading up to activation of downstream targets p70S6K and 
4E-BP1 in TT lymphoblast cells (figure 3b). This suggests 
increased translational activity in TT lymphoblast cells 
compared to CC lymphoblast cells as well as indicates a 
stimulated migratory phenotype that we later confirmed in 
our study. Taken together, these results suggest that Gb3s 
presence stimulates altered protein translation in calcium 
dependent manner involving ERK and mTOR cross talk.
Interestingly, previous reports have shown that Gbg 
signaling regulates Ca2+ fluxes and the exchange protein 
activator of cAMP (Epac) to induce cell migration in 
melanoma cell lines [6]. In Endothelial cells, matrix-
specific down-regulation of cAMP/PKA signaling 
appears to be required for collagen-induced F-actin 
synthesis and stress fiber formation [76]. cAMP also 
inhibits the migration of mouse embryonic fibroblasts 
and 4T1 breast tumor cells by interfering with the 
formation of lamellipodia at the leading edge during cell 
migration. 
Y-14 phosphorylation of Cav1 is known to be necessary 
for binding of Cav1 to intermediate filaments, which in 
turn is required for anterior polarisation at focal adhesion 
sites for directional transmigration in cells [78, 79]. 
Furthermore, phosphorylation of Cav1 is an important 
mechanism for maintaining caveolin hetero- and 
homo-oligomers and for scaffolding and recruitment of 
signaling components to caveolin associated complexes. 
This results in stabilisation of multiprotein complexes 
between caveolar resident and cytoskeletal proteins to 
regulate cell signaling [80]. Vascular endothelial growth 
factor has been shown to trigger src dependent Cav1 
phosphorylation that resulted in induction of migration 
in myeloma cells. Moreover, Gbg signaling induces Src 
kinase activation to activate caveolae by establishment 
of cell polarity [39]. Previous studies have shown that 
upon disruption of cytoskeleton using inhibitors (e.g.: 
cytochalasin D), the levels of cAMP increased, thereby, 
causing aberration in signal transduction (81). We found 
induction of phospho Cav1 (figure 4a) to reorganise actin 
filament structure and enhance stress fibers (figure 5 & 
6) through downregulation of cAMP (figure 4b). Hence, 
the induction of Cav1 phosphorylation and establishment 
of actin stress fibers in the presence of Gβ3s represents 
itself as the downstream mechanism of altered signaling 
leading to enhanced migration. 
Gb3s is primarily implicated in predisposition 
to hypertension and various cardiac diseases [9]. 
Importantly, previous studies in hypertensive rat 
models have demonstrated that a common point in 
downstream signaling after Ca2+ sensitisation and a 
critical component of hypertension is activation of 
RhoA and subsequent activation of Rho-kinase [82]. 
Therefore, the discovery that Gb3s induced hyper Ca2+ 
influx that led to enhanced expression and activation of 
RhoA significantly contributes towards our understanding 
of the increased cancer relapse in certain tumors and 
hypertension pathology where enhanced kinetics of 
migration is a prominent phenomenon. Altogether, the 
current investigation suggests that the enhanced signaling 
pattern induced by the Gβ3s subunit could be one of the 
contributing factors of increased migration and metastasis 
observed in c.825C>T patients with bladder carcinoma 
and low grade breast tumours [18, 19]. This provides 
an opportunity to devise therapeutic strategies that 
specifically target Gβ3 signaling. This strongly suggests 
a rationale for developing tools for Gβ3s allele specific 
inhibition as future therapy in these patients. 
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